Search Results for: RBX1

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
UBE2D1 ubiquitin conjugating enzyme E2 D1
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • TICAM1, RIP1-mediated IKK complex recruitment
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • APC/C:Cdc20 mediated degradation of Securin
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Cdc20:Phospho-APC/C mediated degradation of Cyclin A
  • Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
  • Regulation of APC/C activators between G1/S and early anaphase
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Phosphorylation of the APC/C
  • APC-Cdc20 mediated degradation of Nek2A
  • Signaling by BMP
  • Downstream TCR signaling
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • Separation of Sister Chromatids
  • Senescence-Associated Secretory Phenotype (SASP)
  • FCERI mediated NF-kB activation
  • CLEC7A (Dectin-1) signaling
  • Ovarian tumor domain proteases
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional Regulation by VENTX
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Neddylation
  • Peroxisomal protein import
  • Negative regulators of DDX58/IFIH1 signaling
  • IKK complex recruitment mediated by RIP1
  • Aberrant regulation of mitotic exit in cancer due to RB1 defects
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2D2 ubiquitin conjugating enzyme E2 D2
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • TICAM1, RIP1-mediated IKK complex recruitment
  • Downstream TCR signaling
  • FCERI mediated NF-kB activation
  • CLEC7A (Dectin-1) signaling
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Neddylation
  • Peroxisomal protein import
  • Negative regulators of DDX58/IFIH1 signaling
  • IKK complex recruitment mediated by RIP1
  • Antigen processing: Ubiquitination & Proteasome degradation
  • (R,R)-2,3-Butanediol
UBE2D3 ubiquitin conjugating enzyme E2 D3
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • TICAM1, RIP1-mediated IKK complex recruitment
  • Signaling by BMP
  • Downregulation of SMAD2/3:SMAD4 transcriptional activity
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Neddylation
  • Peroxisomal protein import
  • Negative regulators of DDX58/IFIH1 signaling
  • IKK complex recruitment mediated by RIP1
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2E1 ubiquitin conjugating enzyme E2 E1
  • ISG15 antiviral mechanism
  • Inactivation of APC/C via direct inhibition of the APC/C complex
  • APC/C:Cdc20 mediated degradation of Cyclin B
  • Autodegradation of Cdh1 by Cdh1:APC/C
  • APC/C:Cdc20 mediated degradation of Securin
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Cdc20:Phospho-APC/C mediated degradation of Cyclin A
  • Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
  • Regulation of APC/C activators between G1/S and early anaphase
  • APC/C:Cdc20 mediated degradation of mitotic proteins
  • Phosphorylation of the APC/C
  • APC-Cdc20 mediated degradation of Nek2A
  • Separation of Sister Chromatids
  • Senescence-Associated Secretory Phenotype (SASP)
  • CDK-mediated phosphorylation and removal of Cdc6
  • Transcriptional Regulation by VENTX
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Aberrant regulation of mitotic exit in cancer due to RB1 defects
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2E2 ubiquitin conjugating enzyme E2 E2
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2E3 ubiquitin conjugating enzyme E2 E3
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2G1 ubiquitin conjugating enzyme E2 G1
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2G2 ubiquitin conjugating enzyme E2 G2
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2L3 ubiquitin conjugating enzyme E2 L3
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • E3 ubiquitin ligases ubiquitinate target proteins
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2L6 ubiquitin conjugating enzyme E2 L6
  • ISG15 antiviral mechanism
  • DDX58/IFIH1-mediated induction of interferon-alpha/beta
  • Termination of translesion DNA synthesis
  • Negative regulators of DDX58/IFIH1 signaling
  • Negative regulators of DDX58/IFIH1 signaling
  • Amyloid fiber formation
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2M ubiquitin conjugating enzyme E2 M
  • TGF-beta receptor signaling activates SMADs
  • Dectin-1 mediated noncanonical NF-kB signaling
  • NIK-->noncanonical NF-kB signaling
  • Neddylation
  • Antigen processing: Ubiquitination & Proteasome degradation
UBE2R2 ubiquitin conjugating enzyme E2 R2
  • Synthesis of active ubiquitin: roles of E1 and E2 enzymes
  • Antigen processing: Ubiquitination & Proteasome degradation
VHL von Hippel-Lindau tumor suppressor
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
  • SUMOylation of ubiquitinylation proteins
  • Neddylation
  • Replication of the SARS-CoV-1 genome
  • Replication of the SARS-CoV-2 genome
  • RHOBTB3 ATPase cycle
  • Antigen processing: Ubiquitination & Proteasome degradation
  • Renal cell carcinoma
  • von Hippel-Lindau syndrome
  • Congenital polycythemia; Familial erythrocytosis (ECYT)
VRK2 VRK serine/threonine kinase 2

Page 4 out of 4 pages